NCT00392223 - Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Acne Vulgaris

Interventions

DRUG

Azithromycin microspheres

Azithromycin microspheres, powder for oral suspension, 2 g a week, in unique administration PO, repeated weekly for 8 weeks and minocycline-placebo capsules daily for 8 weeks plus minocycline placebo

DRUG

minocycline-placebo capsules

minocycline-placebo capsules daily for 8 weeks plus minocycline placebo

DRUG

Azithromycin microspheres-placebo

Minocycline capsules, PO, 100 mg daily for 8 weeks and Azithromycin microspheres-placebo once a week for 8 weeks plus azithromycin placebo.

DRUG

Minocycline capsules,

Capsules, PO, 100 mg daily for 8 weeks.

Trial Locations (17)

16132

Pfizer Investigational Site, Genova

20100

Pfizer Investigational Site, Milan

33013

Pfizer Investigational Site, Germona Del Friuli

33170

Pfizer Investigational Site, Pordenone

34100

Pfizer Investigational Site, Trieste

40121

Pfizer Investigational Site, Bologna

44100

Pfizer Investigational Site, Ferrara

53100

Pfizer Investigational Site, Siena

55100

Pfizer Investigational Site, Lucca

56126

Pfizer Investigational Site, Pisa

80131

Pfizer Investigational Site, Napoli

88100

Pfizer Investigational Site, Catanzaro

95124

Pfizer Investigational Site, Catania

98100

Pfizer Investigational Site, Messina

00161

Pfizer Investigational Site, Roma

00167

Pfizer Investigational Site, Roma

05100

Pfizer Investigational Site, Terni